Cardinal Health will look for M&A. Jason Hollar Chief Executive Officer said during the First Quarter Financial Year 2024 Earnings Conference Call, "With our financial flexibility, we'll continue to opportunistically evaluate disciplined M&A in specialty and potential additional share repurchases. We continue to agilely evaluate a range of potential partners or acquisition candidates for both the downstream and upstream elements for our specialty strategy, but clear that our long-term growth targets are not predicated on inorganic investment".
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
98.04 USD | -1.50% | -0.56% | -2.74% |
05-07 | Cardinal Health Board of Directors Approves Increase to Quarterly Dividend, Payable on July 15, 2024 | CI |
05-07 | Deutsche Bank Adjusts Price Target on Cardinal Health to $110 From $116 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.74% | 23.88B | |
+19.79% | 72.09B | |
+11.98% | 8.89B | |
+9.15% | 8.46B | |
-17.39% | 8.29B | |
+7.33% | 4.9B | |
+17.69% | 4.34B | |
-3.66% | 3.98B | |
-2.54% | 3.89B | |
+29.14% | 3.86B |
- Stock Market
- Equities
- CAH Stock
- News Cardinal Health, Inc.
- Cardinal Health Seeks M&A